Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Without Psychotic Features”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableUnknownNCT02501226
What this trial is testing

Effectiveness of the First French Psychoeducational Program on Unipolar Depression

Who this might be right for
Unipolar Depressed OutpatientsMild SeverityWithout Psychotic Features
University Hospital, Montpellier 332
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Not applicableEnded earlyNCT01310140
What this trial is testing

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Who this might be right for
Major Depressive DisorderMajor Depressive Disorder w/ Psychotic FeaturesMetabolic Syndrome
Massachusetts General Hospital 14
Post-approval studies (Phase 4)Study completedNCT01670019
What this trial is testing

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

Who this might be right for
Major Depressive Disorder Without Psychotic Features
Duke University 46
Large-scale testing (Phase 3)Study completedNCT00036309
What this trial is testing

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Who this might be right for
Depressive Disorder
Eli Lilly and Company
Large-scale testing (Phase 3)Study completedNCT00035321
What this trial is testing

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 600